Cold Atmospheric Plasma Activates Selective Photothermal Therapy of Cancer.
Ontology highlight
ABSTRACT: Due to the body's systemic distribution of photothermal agents (PTAs), and to the imprecise exposure of lasers, photothermal therapy (PTT) is challenging to use in treating tumor sites selectively. Striving for PTT with high selectivity and precise treatment is nevertheless important, in order to raise the survival rate of cancer patients and lower the likelihood of adverse effects on other body sections. Here, we studied cold atmospheric plasma (CAP) as a supplementary procedure to enhance selectivity of PTT for cancer, using the classical photothermic agent's gold nanostars (AuNSs). In in vitro experiments, CAP decreases the effective power of PTT: the combination of PTT with CAP at lower power has similar cytotoxicity to that using higher power irradiation alone. In in vivo experiments,
SUBMITTER: Qin J
PROVIDER: S-EPMC9502787 | biostudies-literature | 2022 Sep
REPOSITORIES: biostudies-literature
ACCESS DATA